These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25478215)

  • 1. Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women.
    Zaleski AL; Mentch ML; Pescatello LS; Taylor BA; Capizzi JA; Grimaldi AS; Clarkson PM; Moeckel-Cole SA; Chipkin SR; Keadle J; White CM; Thompson PD
    Cholesterol; 2014; 2014():720507. PubMed ID: 25478215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of 25-Hydroxyvitamin D With the Blood Pressure Response to Maximal Exercise Among Healthy Adults.
    Zaleski A; Taylor B; Armstrong B; Puglisi M; Clarkson P; Chipkin S; White CM; Thompson PD; Pescatello LS
    Int J Sport Nutr Exerc Metab; 2019 May; 29(3):303-308. PubMed ID: 30160549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of endothelial function and the peak systolic blood pressure response to a graded maximal exercise test.
    Olson KM; Augeri AL; Seip RL; Tsongalis GJ; Thompson PD; Pescatello LS
    Atherosclerosis; 2012 May; 222(1):202-7. PubMed ID: 22325930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study.
    Plat J; Severins N; Morrison S; Mensink RP
    Br J Nutr; 2017 Apr; 117(7):942-950. PubMed ID: 28485264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study.
    Singh JP; Larson MG; Manolio TA; O'Donnell CJ; Lauer M; Evans JC; Levy D
    Circulation; 1999 Apr; 99(14):1831-6. PubMed ID: 10199879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension.
    Wong GW; Boyda HN; Wright JM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.
    Magen E; Viskoper R; Mishal J; Priluk R; Berezovsky A; Laszt A; London D; Yosefy C
    Isr Med Assoc J; 2004 Dec; 6(12):742-6. PubMed ID: 15609886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial blood pressure behavior during progressive muscular exercise in subjects with stable arterial hypertension].
    Seguro C; Sau F; Zedda N; Scano G; Cherchi A
    Cardiologia; 1991 Nov; 36(11):867-77. PubMed ID: 1817759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peak systolic blood pressure on a graded maximal exercise test and the blood pressure response to an acute bout of submaximal exercise.
    Syme AN; Blanchard BE; Guidry MA; Taylor AW; Vanheest JL; Hasson S; Thompson PD; Pescatello LS
    Am J Cardiol; 2006 Oct; 98(7):938-43. PubMed ID: 16996879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated exercise blood pressure response in middle-aged men as a predictor of future blood pressure: a 10-year follow-up.
    Ito K; Iwane M; Miyai N; Uchikawa Y; Mugitani K; Mohara O; Shiba M; Arita M
    Clin Exp Hypertens; 2016; 38(8):696-700. PubMed ID: 27936961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can blood pressure responses to tests unmask future blood pressure trends and the need for antihypertensive medication? Ten years of follow-up.
    Jokiniitty J; Majahalme S; Kähönen M; Tuomisto MT; Turjanmaa V
    Clin Physiol Funct Imaging; 2002 Mar; 22(2):125-33. PubMed ID: 12005154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response to exercise is exaggerated in normotensive diabetic patients.
    Karavelioglu Y; Karapinar H; Gul İ; Kucukdurmaz Z; Yilmaz A; Akpek M; Kaya MG
    Blood Press; 2013 Feb; 22(1):21-6. PubMed ID: 22784362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress.
    Kuklińska AM; Mroczko B; Musiał WJ; Sawicki R; Kozieradzka A; Usowicz-Szaryńska M; Kamiński K; Knapp M; Szmitkowski M
    Pharmacol Rep; 2010; 62(5):883-90. PubMed ID: 21098871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characters available in photoplethysmogram for blood pressure estimation: beyond the pulse transit time.
    Li Y; Wang Z; Zhang L; Yang X; Song J
    Australas Phys Eng Sci Med; 2014 Jun; 37(2):367-76. PubMed ID: 24722801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome.
    Kim CH; Wheatley-Guy CM; Stewart GM; Yeo D; Shen WK; Johnson BD
    Blood Press; 2020 Feb; 29(1):47-54. PubMed ID: 31394939
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure responses to whole-body cold exposure: effect of carvedilol.
    Komulainen S; Tähtinen T; Rintamäki H; Virokannas H; Keinänen-Kiukaanniemi S
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):637-42. PubMed ID: 11214769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension.
    Wong GW; Wright JM
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD007452. PubMed ID: 24585007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between Postexercise Hypotension and Heart Rate Variability before and after Exercise Training.
    Cilhoroz BT; Zaleski A; Taylor B; Fernandez AB; Santos LP; Vonk T; Thompson PD; Pescatello LS
    J Cardiovasc Dev Dis; 2023 Feb; 10(2):. PubMed ID: 36826560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.